Akebia Ther Stock Target Price and Analyst Consensus

AKBA Stock  USD 2.30  0.01  0.44%   
The current analyst and expert consensus on Akebia Ther is Strong Buy, with only one strong buy opinion. The current projected Akebia Ther target price consensus is 5.50 with 3 analyst opinions. Check out Macroaxis Advice on Akebia Ther to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
For information on how to trade Akebia Stock refer to our How to Trade Akebia Stock guide.
The most common way Akebia Ther analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Akebia Ther executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Akebia Ther. We encourage you to use your own analysis of Akebia Ther to validate this buy or sell advice. Akebia Ther buy-or-sell recommendation module provides average expert sentiment on the projected Akebia Ther target price to derive its highest and lowest estimates based on projected price volatility of 3.7217.
Lowest Forecast
5.01
Highest Forecast
6.11
Target Price
5.5
The current year's Gross Profit Margin is expected to grow to 0.58, whereas Gross Profit is forecasted to decline to about 89.9 M. At present, Akebia Ther's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Total Current Liabilities is expected to grow to about 130.9 M, whereas Other Current Liabilities is forecasted to decline to about 67.9 M.
  
It's important to approach Akebia Ther's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.

Akebia Ther Target Price Consensus

Akebia target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Akebia Ther's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
   3  Strong Buy
Most Akebia analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Akebia stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Akebia Ther, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Akebia Ther Target Price Projection

Akebia Ther's current and average target prices are 2.30 and 5.50, respectively. The current price of Akebia Ther is the price at which Akebia Ther is currently trading. On the other hand, Akebia Ther's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Akebia Ther Market Quote on 30th of January 2025

Low Price2.29Odds
High Price2.35Odds

2.3

Target Price

Analyst Consensus On Akebia Ther Target Price

Low Estimate5.01Odds
High Estimate6.11Odds

5.5

Historical Lowest Forecast  5.01 Target Price  5.5 Highest Forecast  6.11
Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Akebia Ther and the information provided on this page.

Akebia Ther Analyst Ratings

Akebia Ther's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Akebia Ther stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Akebia Ther's financials, market performance, and future outlook by experienced professionals. Akebia Ther's historical ratings below, therefore, can serve as a valuable tool for investors.

Analyst Consensus Breakdown

Average Consensus Estimates

Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize Akebia Ther price targets

Akebia Ther's stock target price is an estimate of its future price, usually made by analysts. Using Akebia Ther's target price to determine if it is a suitable investment can be done through the following steps:
  • Look at Akebia Ther's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Akebia Ther's stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional Akebia Ther Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Akebia Ther is a key component of Akebia Ther valuation and have some predictive power on the future returns of a Akebia Ther.
Hype
Prediction
LowEstimatedHigh
0.122.356.10
Details
Intrinsic
Valuation
LowRealHigh
0.153.096.84
Details
Naive
Forecast
LowNextHigh
0.052.446.19
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.07-0.07-0.07
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Akebia Ther. Your research has to be compared to or analyzed against Akebia Ther's peers to derive any actionable benefits. When done correctly, Akebia Ther's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Akebia Ther.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Power Assets Idea
Power Assets
Invested over 300 shares
Automobiles and Trucks Idea
Automobiles and Trucks
Invested over 50 shares
Business Services Idea
Business Services
Invested over 100 shares
Driverless Cars Idea
Driverless Cars
Invested few shares
Banking Idea
Banking
Invested over 30 shares
Baby Boomer Prospects Idea
Baby Boomer Prospects
Invested over 60 shares
Warren Buffett Holdings Idea
Warren Buffett Holdings
Invested few shares
Hedge Favorites Idea
Hedge Favorites
Invested over 60 shares
Chemicals Idea
Chemicals
Invested over 30 shares
Artificial Intelligence Idea
Artificial Intelligence
Invested few shares
When determining whether Akebia Ther offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Akebia Ther's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Akebia Ther Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Akebia Ther Stock:
Check out Macroaxis Advice on Akebia Ther to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
For information on how to trade Akebia Stock refer to our How to Trade Akebia Stock guide.
You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Please note, the presentation of Akebia Ther's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Akebia Ther's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Akebia Ther's management manipulating its earnings.